UPDATE 1-Endologix says gets unsolicited bid from hedge fund

(Recasts; adds details, background) Oct 15 (Reuters) - Endologix Inc (ELGX.O) said it received an unsolicited takeover bid from hedge fund Elliott Associates LP for $2.25 a share, 18 percent higher than the stock's Wednesday closing price.

The company, which develops and manufactures minimally invasive treatments for vascular diseases, said it will review the unsolicited proposal and make a determination and respond in due course.

Endologix asked its stockholders to defer judgment on the unsolicited proposal until that determination has been made.

Also on Wednesday, New York-based Elliott took its $529 million cash offer for Epicor Software Corp (EPIC.O) directly to shareholders, two days after it was snubbed by the business software maker's board. [nBNG397251]

Elliott, along with its associates, collectively has more than $14 billion of capital under management.

Endologix shares closed at $1.90 Wednesday on Nasdaq. (Reporting by Supantha Mukherjee in Bangalore; Editing by Amitha Rajan)